Cure Alzheimer's Fund Cure Alzheimer's Fund

G2T Research Models and Materials

2014 to 2025

Taconic Biosciences GMBH, a global provider of genetically modified mouse models and associated services, is providing customized mouse models (transgenic, conventional/conditional knock out, conventional/conditional knock in) for each specific gene and type of mutation that will be studied in the Genes to Therapies™ project.

Foundational Biological Research Materials: New Animal and Cellular Models, and Human Samples Taconic Biosciences

Funding to Date

$12,419,673

Focus

Biological Research Materials: New Animal and Cellular Models, and Human Samples, Foundational

Researchers

Taconic Biosciences

Related Content:


Advancing Late-Onset Alzheimer’s Disease Modeling Through Identification of Neurodegeneration Genes and Vulnerable Neuronal Subtypes Andrew S. Yoo 2026-02-13 G2T Research Models and Materials Taconic Biosciences 2025-12-31 From Molecular Heterogeneity to Predictive Medicine: Transforming Neurodegenerative Disease Research Through Spatial Multiomics and Interpretable AI Genevieve Stein-O’Brien 2025-12-18 Decoding Protein Transport Across the Blood-Brain Barrier to Enable New Alzheimer’s Therapies Andrew Yang 2025-12-16 Engineering a Human Region-Specific System to Probe APOE-Linked Cellular Vulnerability and Resilience in Alzheimer’s Disease Mehdi Jorfi 2025-12-16 2025 Jeffrey L. Morby Prize for Exceptional Research Andrew S. Yoo 2025-06-08 Investigating the Serial Pathologies Related to Plasma Biomarkers in NLFTaum/h Mice: A New Mouse Model Featuring Neurofibrillary Tangles as a Result of Rising Amyloid Beta without Microtubule-Associated Protein Tau (MAPT) Mutations Frances Edwards John Hardy 2024-12-16 Characterization and Validation of Two Recently Created Sheep Models of Alzheimer’s Disease in Preparation for Use as a Preclinical Pharmaceutical Testing Model Russell G. Snell Natasha McKean 2024-01-31